In a dramatic move, Attorney General Pam Bondi has fired a Justice Department employee accused of disrespecting National Guard members. This incident raises questions about conduct within the federal workforce.
In a letter to Attorney General Pam Bondi and FBI Director Kash Patel, congressional Democrats express grave concerns over the gutting of anti-corruption efforts, citing a troubling trend of politicization in the Justice Department amid rising corruption during the Trump Administration.
Get ready for a gripping new limited series on the Karen Read trial, featuring Elizabeth Banks! This true crime story explores the shocking events surrounding a Boston police officer's death and the ensuing controversy.
Republicans are outraged after the Senate parliamentarian ruled against key measures in their tax and immigration bill. This controversy highlights the parliamentarian's pivotal role in shaping legislation.
In a groundbreaking announcement, Trump is set to reveal details about the Golden Dome missile defense shield, a massive project that could reshape military strategy with its extensive satellite network. Will funding hurdles jeopardize this ambitious plan?
Billy Evans, partner of Theranos founder Elizabeth Holmes, is launching a new blood-testing venture called Haemanthus, raising eyebrows and questions about repeating past mistakes in health technology.
Discover the crucial insights from Fortune Media that could change your financial game. Don't miss the essential tips and updates that Fortune provides!
Good Monday morning! NYC is buzzing with news as safety metrics soar thanks to congestion pricing, while legal weed shops face vape sales halts and Andrew Yang stumbles in comedy. Plus, Bob Menendez's prison date delay and Elizabeth Holmes' husband seeks funds for a new venture!
Billy Evans, partner of Theranos founder Elizabeth Holmes, is raising millions for Haemanthus, a new blood-testing company with striking similarities to its infamous predecessor. Can he succeed where Holmes failed?
Billy Evans, partner of Theranos founder Elizabeth Holmes, unveils Haemanthus, a startup aiming to revolutionize health optimization through advanced blood testing. With ambitions to raise over $50 million, this venture echoes Theranos' controversial legacy. Is it a groundbreaking innovation or a repeat of past mistakes?
